Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Clinical trial NCT07611513 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07611513
Sponsor: Sinovac Biotech Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hand, Foot, and Mouth Disease(HFMD)Herpangina

Start date: 2026-05-01
Primary completion: 2027-12-01
Enrollment: 6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.